
Novocure Ltd
NASDAQ:NVCR

Intrinsic Value
The intrinsic value of one
NVCR
stock under the Base Case scenario is
25.27
USD.
Compared to the current market price of 16.33 USD,
Novocure Ltd
is
Undervalued by 35%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Novocure Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Novocure Ltd
Balance Sheet Decomposition
Novocure Ltd
Current Assets | 1.1B |
Cash & Short-Term Investments | 929.1m |
Receivables | 118.6m |
Other Current Assets | 41.6m |
Non-Current Assets | 159.5m |
PP&E | 145m |
Other Non-Current Assets | 14.5m |
Free Cash Flow Analysis
Novocure Ltd
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Novocure Ltd
Revenue
|
621.7m
USD
|
Cost of Revenue
|
-142m
USD
|
Gross Profit
|
479.7m
USD
|
Operating Expenses
|
-646.5m
USD
|
Operating Income
|
-166.8m
USD
|
Other Expenses
|
2.7m
USD
|
Net Income
|
-164.2m
USD
|
NVCR Profitability Score
Profitability Due Diligence
Novocure Ltd's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

Score
Novocure Ltd's profitability score is 22/100. The higher the profitability score, the more profitable the company is.
NVCR Solvency Score
Solvency Due Diligence
Novocure Ltd's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Score
Novocure Ltd's solvency score is 31/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NVCR Price Targets Summary
Novocure Ltd
According to Wall Street analysts, the average 1-year price target for
NVCR
is 34 USD
with a low forecast of 27.27 USD and a high forecast of 42 USD.
Dividends
Current shareholder yield for NVCR is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
NVCR
stock under the Base Case scenario is
25.27
USD.
Compared to the current market price of 16.33 USD,
Novocure Ltd
is
Undervalued by 35%.